Drug ID: | NPD2393 |
Drug Name: | |
Molecular Formula: | C17H16O6 |
Canonical SMILES: | Oc1ccc(cc1O)C1CC(=O)c2c(O1)c(C)c(c(c2O)C)O |
Standard InCHI: | InChI=1S/C17H16O6/c1-7-15(21)8(2)17-14(16(7)22)12(20)6-13(23-17)9-3-4-10(18)11(19)5-9/h3-5,13,18-19,21-22H,6H2,1-2H3 |
Standard InCHIKey: | AESMRHCYHARBLU-UHFFFAOYSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB006966 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 316.09 |
ALogP | -0.9907 |
MLogP | 2.67 |
XLogP | 0.587 |
HDA | 1 |
HBD | 4 |
Rotatable Bonds | 7 |
TPSA | 107.22 |
RO5 Violation | 0 |